EKR THERAPEUTICS, INC.
COMPREHENSIVE COMPLIANCE PROGRAM

EKR Therapeutics, Inc. ("EKR" or the "Company") has a Comprehensive Compliance Program that reflects the Company's commitment to compliance with the full range of laws, regulations and policies that govern pharmaceutical marketing and selling activities in the United States. EKR's Comprehensive Compliance Program is consistent with (i) the recommendations set forth in "Compliance Program Guidance for Pharmaceutical Manufacturers" published by the Office of Inspector General, U.S. Department of Health and Human Services, (ii) the provisions of the Code on Interactions with Healthcare Professionals created by the Pharmaceutical Research and Manufacturers of America ("PhRMA Code") and (iii) the requirements of Sections 119400 and 119402 of the California Health and Safety Code (and California SB 1765). The goal of the Company's Comprehensive Compliance Program is to maintain a culture that promotes the prevention, detection and resolution of potential violations of law or Company policy.

Declaration of Compliance

The Company declares that based upon its good faith understanding of California SB 1765, it is in compliance with the requirements of this law.

If you would like to be mailed a copy of the Company's Comprehensive Compliance Program and the Company's Declaration of Compliance, please call 1 (877) 435-2524 ext. 123 or email a.mironov@ekrtx.com.

To view EKR Therapeutics, Inc Code of Ethics and Business Conduct, please go to Code of Ethics and Business Conduct.